Page History
Session Summary
The use of i2b2 for determining feasibility of clinical studies and clinical trials, focusing on the use of i2b2 in networks across the country, and novel approaches to allowing investigators to perform feasibility studies using i2b2-based client tools.
Section | |||||
---|---|---|---|---|---|
|
Douglas MacFadden
|
P1: SHRINE Update
Review of all the new features added to the SHRINE Software
|
|
Nich Wattanasin, MS
|
P2: Feasibility Studies Using SHRINE and i2b2
|
Button | ||||
---|---|---|---|---|
|
|